Trans:Mission A community-led HIV testing initiative for trans people and their partners at a London sex-on-premises venue

Aedan J. Wolton1,2, Richard Cameron1,2, Michelle Ross-Turner1, Tara Suchak1,2
1cliniQ Community Interest Company; 2Chelsea and Westminster Hospital NHS Foundation
Trust, London, UK

Studies indicate that transgender (trans) communities are particularly vulnerable to HIV. However, trans people in the UK are often excluded from HIV services and research. This evaluation reviews the activity of a trans-led team that provided monthly outreach testing at a trans sex-on-premises venue in London; 133 instant HIV tests were performed between November 2016 and November 2017. Of those tested 39.8% were trans women, 51.8% identified as male, and 17% described themselves as cross-dressers. There were no reactive tests despite a high incidence of unprotected sex. In this study 68.7% of individuals (n=131) had not heard of pre-exposure prophylaxis (PEP) and 74% did not know where to access it. Awareness of post exposure prophylaxis (PrEP) was lower: 83.9% of people had not heard of PrEP, and 86.2% did not know where to access it. This service evaluation highlights the need for greater visibility of trans or non-binary people in PrEP research and campaigns, as well as trans-specific HIV prevention interventions.
Key words: HIV, testing, trans, transgender, pre-exposure prophylaxis, post exposure prophylaxis, community